Albert David (NSE:ALBERTDAVD) Net Current Asset Value: ₹432.46 (As of Mar. 2026) — 20493% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALBERTDAVD Albert David Ltd NSE:ALBERTDAVD
75 GF Score
Price ₹688.75
GF Value ₹818.49
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Albert David Net Current Asset Value?

Albert David NSE:ALBERTDAVD +0.31% 75 Net Current Asset Value is ₹432.46 as of Mar. 2026, which is 100% below its 10-year median of 2.10. GuruFocus rates NSE:ALBERTDAVD with a GF Score™ of 75/100 and a GF Value™ of ₹818.49 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 609 Drug Manufacturers companies, Albert David ranks better than 88.51% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Albert David's net current asset value per share for the quarter that ended in Mar. 2026 was ₹432.46.

The historical rank and industry rank for Albert David's Net Current Asset Value or its related term are showing as below:

NSE:ALBERTDAVD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.36   Med: 2.1   Max: 3.06
Current: 1.58

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Albert David was 3.06. The lowest was 1.36. And the median was 2.10.

NSE:ALBERTDAVD's Price-to-Net-Current-Asset-Value is ranked better than
88.51% of 609 companies
in the Drug Manufacturers industry
Industry Median: 5.7 vs NSE:ALBERTDAVD: 1.58

Albert David  (NSE:ALBERTDAVD) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Albert David Net Current Asset Value Related Terms


Albert David Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for Albert David's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert David Net Current Asset Value Chart

Albert David Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 230.61 337.16 449.66 411.98 432.46

Albert David Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 411.98 0.00 452.25 0.00 432.46

NSE:ALBERTDAVD vs ZTS: Net Current Asset Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Albert David's Price-to-Net-Current-Asset-Value falls into.


NSE:ALBERTDAVD
75GF Score
Albert David Ltd NSE:ALBERTDAVD
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Albert David Net Current Asset Value Calculation

Albert David's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Mar. 2026 is calculated as

Net Current Asset Value Per Share(A: Mar. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3744.029-1275.965-0-0)/5.707
=432.46

Albert David's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2026 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2026 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3744.029-1275.965-0-0)/5.707
=432.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of ₹432.46 mean?
Albert David (NSE:ALBERTDAVD) has a Net Current Asset Value of ₹432.46 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Albert David and its competitors. This is 20493% above median its historical median of 2.10. Over the past decade, Albert David's Net Current Asset Value has ranged from 1.36 to 3.06. According to the industry distribution chart, Albert David ranks #70 out of 609 companies in the Drug Manufacturers industry, placing it in the top 11.5%.
Is Albert David's Net Current Asset Value too high?
Albert David's current Net Current Asset Value of ₹432.46 is 20493% above median its 10-year median of 2.10. Over the past 10 years, this metric has ranged from a low of 1.36 to a high of 3.06. Based on the distribution chart, Albert David ranks #70 out of 609 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Albert David has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Albert David's Net Current Asset Value compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Albert David ranks #70 out of 609 companies for Net Current Asset Value. This places Albert David in the top 12% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 5.70. Historically, Albert David's own Net Current Asset Value has ranged from 1.36 to 3.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 5.70, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Albert David and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Albert David's current Net Current Asset Value is ₹432.46, which is 20493% above median its own 10-year median of 2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert David stock overvalued right now?
Based on GuruFocus' analysis, Albert David (NSE:ALBERTDAVD) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹818.49, compared to a current price of ₹688.75 — trading 15.9% below its estimated fair value. The current Net Current Asset Value is ₹432.46, which is 20493% above median its 10-year median of 2.10. Albert David's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Albert David (NSE:ALBERTDAVD), the current Net Current Asset Value is ₹432.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Albert David (NSE:ALBERTDAVD) Overvalued in 2026?

Based on GuruFocus' analysis, Albert David stock appears to be undervalued. The current stock price of ₹688.75 is trading 15.9% below its estimated GF Value™ of ₹818.49. GuruFocus considers Albert David to be Modestly Undervalued.

Key valuation signals for NSE:ALBERTDAVD:

  • Net Current Asset Value: ₹432.46 (20493% above median its 10-year median of 2.10)
  • GF Value™: ₹818.49 vs. price of ₹688.75 (15.9% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the NSE:ALBERTDAVD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Albert David Business Description

Other Exchanges 524075:India
Address 8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, Southeast Asia, and a few African countries. The Company is only engaged in the manufacturing of pharmaceutical products, ipso facto, one reportable segment.
75GF Score

Get the complete analysis for NSE:ALBERTDAVD

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹688.75
Price
₹818.49
GF Value